• Report details
  • 11 Figures
  • 30 Tables
  • FY19 Corporate R&D Spending Grows Close to 10%
    • Overview
    • Health Industries
    • China
  • New Funding Commitments Announced
    • A Windfall for Antibiotics Research
    • Novozymes Gets R&D Loan
    • $100 Million for City of Hope
    • Support for Precision Medicine
    • Funding for Immunology Research
  • Executive Briefing
    • Cytiva Makes First Purchase
    • Diagnostics Maker Approaches QIAGEN
    • Microsaic Raises New Funding
    • GC Firm Acquired
  • Fourth Quarter 2020 Results: Bio-Techne, Biotage, Fluidigm and Illumina
    • Bio-Techne Continues to Post Strong Sales Growth for Fiscal 2021
    • Biotage Ends 2020 Positively Despite COVID-19 Related Disruptions
      • Q4 & FYE
    • Fluidigm Finishes 2020 on a High Note
      • Q4 & FYE
    • Illumina Sees Pockets of Growth in 2020
      • Q4 & FYE
  • Market Profile: Surface Plasmon Resonance Analyzers
    • Largest Markets
    • Leading Suppliers
    • Instrument Cost
  • Industry Watch
    • Biopharmaceutical
    • Academia
    • Clinical
  • Region Watch
    • Japan
    • EU
    • UK
  • News
    • Life Science Consumables
      • Company Announcements
      • Gene-based Analysis
      • Company News
      • Product Introductions
      • Sales & Orders of Note
      • Cell-based Analysis
      • Company Announcements
      • Sales and Orders of Note
      • Protein-based Analysis
      • Company Announcements
      • Product Introductions
    • MS & LC/MS
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Chromatography
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Sample Preparation
      • Company Announcements
      • Product Introductions
  • Bottom Line
Attachments
Instrument Business Outlook Volume 29, Issue 21
16 Feb 2021

Request Access
 
Table of Contents
  • FY19 Corporate R&D Spending Grows Close to 10%
    • Overview
    • Health Industries
    • China
  • New Funding Commitments Announced
    • A Windfall for Antibiotics Research
    • Novozymes Gets R&D Loan
    • $100 Million for City of Hope
    • Support for Precision Medicine
    • Funding for Immunology Research
  • Executive Briefing
    • Cytiva Makes First Purchase
    • Diagnostics Maker Approaches QIAGEN
    • Microsaic Raises New Funding
    • GC Firm Acquired
  • Fourth Quarter 2020 Results: Bio-Techne, Biotage, Fluidigm and Illumina
    • Bio-Techne Continues to Post Strong Sales Growth for Fiscal 2021
    • Biotage Ends 2020 Positively Despite COVID-19 Related Disruptions
      • Q4 & FYE
    • Fluidigm Finishes 2020 on a High Note
      • Q4 & FYE
    • Illumina Sees Pockets of Growth in 2020
      • Q4 & FYE
  • Market Profile: Surface Plasmon Resonance Analyzers
    • Largest Markets
    • Leading Suppliers
    • Instrument Cost
  • Industry Watch
    • Biopharmaceutical
    • Academia
    • Clinical
  • Region Watch
    • Japan
    • EU
    • UK
  • News
    • Life Science Consumables
      • Company Announcements
      • Gene-based Analysis
      • Company News
      • Product Introductions
      • Sales & Orders of Note
      • Cell-based Analysis
      • Company Announcements
      • Sales and Orders of Note
      • Protein-based Analysis
      • Company Announcements
      • Product Introductions
    • MS & LC/MS
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Chromatography
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Sample Preparation
      • Company Announcements
      • Product Introductions
  • Bottom Line
Categories
To the Top
More information about this product
Other Users Also Viewed
Instrument Business Outlook Volume 29, Issue 20
1 Feb 2021
Instrument Business Outlook Volume 29 - Issue 18
5 Jan 2021
Instrument Business Outlook Volume 29 - Issue 11
15 Sep 2020
The Worldwide Market for In Vitro Diagnostic Tests, 13th Edition
26 Aug 2020
The Market and Potential for Molecular Point of Care 2021
25 Jan 2021